Alexander O. Schuth - Jan 3, 2023 Form 4/A - Amendment Insider Report for Denali Therapeutics Inc. (DNLI)

Role: COFO and Secretary
Signature: /s/ Tyler Nielsen, by power of attorney
Stock symbol: DNLI
Transactions as of: Jan 3, 2023
Transactions value $: -$83,574
Form type: 4/A - Amendment
Date filed: 1/9/2023, 03:05 PM
Date Of Original Report: Jan 5, 2023
Previous filing: Oct 12, 2022
Next filing: Jan 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DNLI	Common Stock	Sale	-$83.6K	-2.91K	-0.59%	$28.70	492K	Jan 4, 2023	See footnote	F1, F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs.
F2	The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $28.48 to $28.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3	Reflects the issuance of shares to The Schuth Family Trust U/A DTD 06/05/2017 in connection with the vesting of 7,750 RSUs held by the Reporting Person.
F4	The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.

Remarks:

This amended Form 4 is filed because 2,912 shares were sold by The Schuth Family Trust, not by the Reporting Person.